Business description: Abcam plc

Number of employees: 1,760
Sales by Activity: Abcam plc
| Fiscal Period: December | 2019 (GBP) | 2020 (GBP) | 2021 (GBP) | 2022 (GBP) |
|---|---|---|---|---|
Sales of Antibodies and Related Products | 260M | 260M | 315M | 362M |
Geographical breakdown of sales: Abcam plc
| Fiscal Period: December | 2019 (GBP) | 2020 (GBP) | 2021 (GBP) | 2022 (GBP) |
|---|---|---|---|---|
The Americas | - | 112M | 130M | 162M |
EMEA | - | 69.3M | 84.3M | 90.1M |
China | 39.9M | 39.5M | 58.2M | 62.9M |
Rest of Asia | - | 20M | 23.8M | 28.3M |
Japan | 16.9M | 18.8M | 18.7M | 17.9M |
United Kingdom (UK) | 13.6M | - | - | - |
Other Countries | 58.7M | - | - | - |
Germany | 15.2M | - | - | - |
United States (US) | 116M | - | - | - |
Executive Committee: Abcam plc
| Manager | Title | Age | Since |
|---|---|---|---|
Alan Hirzel
CEO | Chief Executive Officer | 58 | 2014-09-08 |
Michael Baldock
DFI | Director of Finance/CFO | 62 | 2020-02-02 |
Markus Lusser
PSD | President | 58 | 2024-03-17 |
Tommy J. Thomas
IRC | Investor Relations Contact | - | 2022-06-26 |
Sun Yi
SAM | Sales & Marketing | - | 2018-09-30 |
Composition of the Board of Directors: Abcam plc
| Director | Title | Age | Since |
|---|---|---|---|
Alan Hirzel
BRD | Director/Board Member | 58 | 2013-12-31 |
Mara Aspinall
BRD | Director/Board Member | 63 | 2015-09-13 |
Giles Kerr
BRD | Director/Board Member | 67 | 2018-12-11 |
Michael Baldock
BRD | Director/Board Member | 62 | 2020-02-02 |
Luba Greenwood
BRD | Director/Board Member | 47 | 2022-09-11 |
Markus Lusser
BRD | Director/Board Member | 58 | 2025-07-28 |
Company details: Abcam plc

Biopharmaceuticals
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.90% | +3.80% | +41.49% | -0.78% | 83.28B | ||
| +8.86% | +129.20% | +435.14% | +24.85% | 57.94B | ||
| -1.69% | +23.30% | -22.30% | -36.29% | 57.77B | ||
| -1.46% | +0.19% | -2.06% | +30.50% | 51.75B | ||
| +1.74% | +4.43% | +12.37% | +169.64% | 49.35B | ||
| +1.13% | +3.31% | +55.61% | -17.57% | 32.03B | ||
| +0.46% | +6.37% | +50.29% | +97.27% | 25.91B | ||
| +1.19% | +9.17% | +2.97% | +230.86% | 22.74B | ||
| -0.30% | +4.45% | +58.29% | +118.84% | 16.87B | ||
| Average | +1.20% | +20.47% | +70.20% | +68.59% | 44.18B | |
| Weighted average by Cap. | +1.44% | +24.98% | +80.52% | +46.37% |

















